New Study Released on Fotona's NightLase® Anti-Snoring Laser Treatment

July 2022

Fotona's NightLase® anti-snoring laser treatment has been gaining worldwide recognition for it's safety and efficacy.

A newly published article by Dr. Valerie A. Picavet, et al. in the prestigious European Archives of Oto-Rhino-Laryngology presents the data from a recent study that assessed the safety and efficacy of the minimally invasive NightLase® therapy, comparing the results with a sham treatment.

The authors of the study concluded that:

"NightLase treatment significantly reduced snoring compared to sham treatment. Its efficacy is similar to that achieved with other more aggressive treatments.

Taking into account the minimal invasiveness of NightLase, this procedure seems to represent a valuable, low-risk treatment option for primary snoring/mild OSAS."


It should also be noted that the treatment was well tolerated by patients, with no local anaesthesia required.

The full text of the journal article, titled: Treatment of snoring using a non‑invasive Er:YAG laser with SMOOTH mode (NightLase): a randomized controlled trial, can be viewed on the publisher's website.

Related news

Four New Studies Support the Use of Non-ablative Fotona SMOOTH® Technology for SUI

December 2025

Data all over the world continue to support the effectiveness of Fotona SMOOTH® for Stress Urinary Incontinence.

The 15th Laser & Health Academy Symposium – Inspiring the Next Era of Laser Technology

May 2025

This year’s Symposium was perhaps the most memorable and exciting ever—an event that once again delivered an exceptional and comprehensive educational experience!

Official Opening of New LA&HA Portugal Training Centre

July 2025

The Laser and Health Academy (LA&HA) is proud to announce the official opening of the new LA&HA Portugal Training Centre at the state-of-the-art Clitrofa Clinic.